Catalyst Crew Technologies Consolidates AI IP, Establishes Venezuelan Operating Subsidiary
Summary
Catalyst Crew Technologies Corp. completed the acquisition of a Venezuelan subsidiary from its CEO and formally assigned its core AI healthcare analytics intellectual property to this new entity, streamlining its Latin American operations.
Key Events
-
Acquisition of Wholly-Owned Subsidiary
On March 23, 2026, Catalyst Crew Technologies Corp. completed the acquisition of 100% of Inversiones Long 33, C.A., a Venezuelan corporation, from its Chief Executive Officer, Kevin Rodan Levy. This entity is intended to serve as the company's operating arm in Venezuela and for its broader Latin American strategy.
-
Internal Intellectual Property Assignment
On April 7, 2026, certain intellectual property rights, including CardioAI, PulmoAI, and NeuroAI technologies, previously acquired by the company from its CEO, were formally assigned to the newly acquired Venezuelan subsidiary. This was an internal reorganization step with no additional consideration paid.
-
Strategic Operational Consolidation
The transactions establish a clear operating structure and consolidate key AI healthcare analytics intellectual property under a wholly-owned subsidiary, supporting the company's strategic expansion into Latin American markets.
Analysis
Catalyst Crew Technologies Corp. has formalized its operational structure for its Latin American strategy by completing the acquisition of Inversiones Long 33, C.A., a Venezuelan subsidiary, from its CEO. This move is significant as it consolidates the company's core artificial intelligence-enabled healthcare analytics intellectual property (CardioAI, PulmoAI, NeuroAI) within this new wholly-owned entity. While the initial IP acquisition from the CEO was previously disclosed, this filing details the subsequent internal reorganization, which is a crucial step in establishing a clear operating framework for future regional expansion. Investors should view this as a foundational step to streamline operations and intellectual property management for its stated strategic goals.
At the time of this filing, CCTC was trading at $1.57 on OTC in the Technology sector, with a market capitalization of approximately $46M. The 52-week trading range was $0.27 to $675.01. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.